Condition: Intraventricular Hemorrhage · Subarachnoid Hemorrhage · Subdural Hematoma · Sponsor: Ohio State University
The goal of this clinical trial is to evaluate efficacy and safety of evacuation of cerebrospinal fluid, blood, and harmful bacteria from the intraventricular, subdural and subarachnoid spaces by Active Controlled Irrigation and Drainage (IRRAflow) compared to Passive External Ventricular Drainage (EVD). Subjects with intraventricular hemorrhage, subarachnoid hemorrhage, subdural bleeding, and ventriculitis will be randomized to receive the IRRAflow device or EVD device and followed for one month post-procedure to compare outcomes between the subject groups.
This description comes directly from the study's public registry record.
Edouard Beliaire · 6143666936 · edouard.belizaire@osumc.edu
Patrick Youssef, MD · 6143666590 · patrick.youssef@osumc.edu
Always discuss trial participation with your own doctor first.
| The Ohio State University Wexner Medical Center | Columbus, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05649904